venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 7
- −1 vs. Q3 2023
- Portfolio value
- $667.2M
- +$314.5M (+89.2%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RYZBRayzeBio, Inc. | COM | 5,158,162 | $320.7M | 48.1% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $144.4M | 21.6% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 4,919,504 | $138.0M | 20.7% | +654,832+15.4% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,035,396 | $33.4M | 5.0% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 3,852,470 | $28.7M | 4.3% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,914,255 | $1.56M | 0.2% | 00.0% | Unchanged | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $340.8K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2023 (1)
Positions held at the end of Q3 2023 that are gone from this filing.